KAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS F

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to provide key highlights of the clinical...

Related Keywords

United States , San Francisco , California , Sydney , New South Wales , Australia , America , Sabine Mueller , Brandon Imber , Evangeliner Jackson , Ryan Duchatel , John Friend , Twitter , Memorial Sloan Kettering Cancer Center , Prnewswire Kazia Therapeutics Limited , Genentech , University Of Newcastle , Society Of Neuro , Drug Administration , Kazia Therapeutics Limited , Therapeutics Limited , Diffuse Midline , North America , Overall Survival , Progression Free Survival , Kazia Therapeutics , Fast Track Designation , Pediatric Disease ,